Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer

This cohort study examines the association between prostate-specific membrane antigen positron emission tomography use and initial prostate cancer treatment.

Corresponding Author: Michael S. Leapman, MD, MHS, Yale School of Medicine, 789 Howard Ave, Fitkin 300, PO Box 208058, New Haven, CT 06520 (michael.leapman@yale.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.